Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • luc
    Senior Member
    • Dec 2010
    • 469

    #31
    But counting applications are much better served by the HiSeq - if one does not need immediate turnaround.


    Originally posted by M4TTN View Post
    Info from Illumina:

    The MiniSeq is similar to the technology utilised with our NextSeq platform based on 2-channel SBS chemistry.

    Pricing Information

    MiniSeq System (SY-420-1001): £35,653
    MiniSeq Basic Plan (20004132): £3,350 for 1 additional year’s cover
    MiniSeq Comprehensive Plan (20004133): £4,021 for 1 additional year’s cover

    Code:
    High Output Kit 	2 x 150 (300bp)	7.5	25	FC-420-1003	1,046
    High Output Kit 	2 x 75 (150 bp)	3.75	25	FC-420-1002	652
    High Output Kit 	1 x 75 (75 bp)	1.875	25	FC-420-1001	558
    Mid  Output Kit	2 x 150 (300 bp)	2.4	8	FC-420-1004	384
    So upfront and service costs are half a MiSeq.
    Output for counting experiments is the same as MiSeq v3 chemistry (25 M reads)
    The only thing it lacks are long paired reads 2x300 bp (but those kits are failing at the moment anyway...) and with NexteraXT many of our fragments are shorter than 300 bp anyway...

    I think knowing what I know now...I'd probably buy one...specs are only going to improve.

    Comment

    • M4TTN
      Member
      • Jan 2014
      • 77

      #32
      Depends on how many reads you need...we are multiplexing 5-8 samples quite nicely on a MiSeq (counting expt). No need to go to higher depth for us (at least not at the moment).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Working...